contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
      researchContentUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


rettelse-monsenso-underskriver-stor-kommerciel-ordre-med-privat-international-sundhedsudbyder

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Monsenso operates in the IT sector. The company specializes in digital monitoring systems for healthcare and hospitals. The solutions are software-based and are mainly used for monitoring patients' health, as well as for internal monitoring and analysis. The largest operations are in the Nordic market. The headquarters are located in Copenhagen.

Monsenso

20.3.2026 11:54:38 CET | Monsenso | Intern videnSelskabsmeddelelse nr. 02-2026København, den 19. marts 2026Denne meddelelses indeholder intern videnI vores årsrapport for 2025 (note 2) skrev...

20.3.2026 11:54:38 CET | Monsenso | Intern videnSelskabsmeddelelse nr. 02-2026København, den 19. marts 2026Denne meddelelses indeholder intern videnI vores årsrapport for 2025 (note 2) skrev vi, at forhandlingerne omkring en større ordre var i sin afsluttende fase. Denne ordre er nu blevet underskrevet. Det ændrer ikke vores forventninger til omsætningen for 2026, men det reducerer de finansielle risici, vi tidligere har nævnt. Vi planlægger også at rejse yderligere kapital i andet kvartal af 2026.Aftalen handler om at opsætte og levere Monsensos digitale sundhedsplatform til en international, privat udbyder af sundhedsydelser. Platformen skal benyttes til at indsamle patient-rapporterede data, støtte justering af medicin, give patienter information om deres behandling samt gøre kommunikationen mellem patienter og sundhedspersonale lettere og give en mere personligt tilpasset behandling i eget hjem.”Potentialet for denne ordre er betydeligt. Den indeholder en indledende ordre på opsætning og konfiguration af platformen og vil generere løbende abonnementsindtægter fremover. Der er også et stort potentiale for at udvide til andre sygdomsområder, som kunden allerede arbejder med.” siger Thomas Lethenborg, CEO i Monsenso.Yderligere oplysninger:MonsensoCEO Thomas Lethenborg Tlf. +45 21 29 88 27 E-mail:&nbsp;<a href="mailto:lethenborg@monsenso.com">lethenborg@monsenso.com</a>Bestyrelsesformand Peter Mørch Eriksen E-mail:&nbsp;<a href="mailto:Petermorcheriksen@outlook.com">Petermorcheriksen@outlook.com</a>Certified Adviser:HC Andersen Capital Bredgade 23,&nbsp; 1260 København K&nbsp;<h4>Vedhæftninger</h4><ul> <li> <a href="https://via.ritzau.dk/ir-files/13559904/14846007/17407/Download%20selskabsmeddelelse.pdf">Download selskabsmeddelelse.pdf</a> </li></ul><h4>Original meddelelse</h4><ul> <li><a href="https://via.ritzau.dk/announcement/14844601?publisherId=13559904&amp;lang=da">Monsenso underskriver stor kommerciel ordre med privat, international sundhedsudbyder</a></li></ul>

Rettelse: Monsenso underskriver stor kommerciel ordre med privat, international sundhedsudbyder

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Nordea Bank

Nordea shareholder? It’s easier than ever to attend the AGM with a new digital set-up

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation